Trial Profile
Efficacy and safety of oral famciclovir in patients with active recurrent genital herpes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2013
Price :
$35
*
At a glance
- Drugs Famciclovir (Primary)
- Indications Herpes genitalis
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Dec 2007 Status changed from in progress to completed.
- 26 Feb 2006 New trial record.